The US FDA has approved Amgen's Bkemv as an interchangeable biosimilar to Soliris for the treatment of specific rare diseases ...
Soon after Ozempic was approved by the Food and Drug Administration in 2017 to treat diabetes, it started getting used ...
SILVER SPRING, MD, USA I May 28, 2024 I Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain ...
from the U.S. Food and Drug Administration (FDA) for BE-101, a first-in-class BCM in development for the potential treatment of hemophilia B. The Phase 1/2 clinical trial, BeCoMe-9, is a multi-center, ...
Hon. Uchenna Stephen Igwe is Ebonyi State Honourable Commissioner for Local Government and Chieftaincy Matters. In a chat ...
The UK’s MHRA recently published its guidance on its approach to both regulating the use of AI for drug and medical devices, ...
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Meningococcal Vaccines Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Meningococcal Vaccines Market will surpass ...
MAASTRICHT, Netherlands, May 29, 2024 /PRNewswire/ -- DSM B.V., a 98.5%-owned subsidiary of DSM-Firmenich AG, held its Annual General Meeting of Shareholders (AGM) today in Maastricht, the Netherlands ...
Axios Vitals on MSN50m
Warnings grow about unlicensed cosmetic treatment providersThe increasing demand for cosmetic procedures like Botox injections, dermal fillers and fat-dissolving treatments at popular ...
New symptoms such as the inability to identify multiple objects at once and a "space perception deficit" could be early ...
May 2024. For more information go to our website at or follow us on social media @VivaTech.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results